<DOC>
	<DOCNO>NCT01560481</DOCNO>
	<brief_summary>Metformin Glycinate novel biguanide compound develop potential candidate treatment type 2 diabetes . Metformin Glycinate find improve metabolic control naive patient type 2 diabetes . The objective study evaluate safety , tolerability pK profile Metformin Glycinate 620 mg QD , 1240 mg QD , 2480 mg QD , administration one single dose , step A . In step A include 25 volunteer . In step B objective evaluate Safety , tolerability pK profile Metformin Glycinate 620 mg BID , administration multiple dose 8 day . In step B include 24 volunteer .</brief_summary>
	<brief_title>Clinical Trial Evaluate Safety pK Profile Metformin Glycinate Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Age 18 45 year . Weight within normal range ( Quetelet index 21 26 ) ( weight ( kg ) /height ( m2 ) . Adequate physical examination clinical history No organic psychiatric disorder Normal Blood pressure , Pulse Rate , temperature ECG . Lab test within normal value accord reference lab value Biochemistry lab Hospital Santa Creu I Sant Pau . It allow change accord clinical criterion clinical staff ICIMSANT PAU Females childbearing potential adequate contraceptive precaution , oral contraceptive negative urine pregnancy test . No participation clinical trial within previous two month initiation study . No blood donation within previous four week initiation study . Signed informed consent . Drugs alcohol abuse . Consumer stimulant drink ( &gt; 5 coffee , tea , cola drink ) . Smokers ( &gt; 10 cigar ) . Precedents drug allergy hypersensitivity Intake medication within previous 15 day study . Positive HIV , HBV HCV . Chronic disease ( cardiovascular , respiratory , endocrine , gastrointestinal , hematologic , neurologic others ) . Prior surgery within previous six month initiation study . Pregnant woman breastfeed female childbearing potential adequate contraceptive precaution , oral contraceptive .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>metformin glycinate</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
</DOC>